Topics

Fujifilm Announces The Introduction of a 10 week Cell Line Development Timeline with Its Apollo™ X Advanced Mammalian Expression System

11:53 EDT 23 Apr 2019 | Lab Bulletin

20190412_1FUJIFILM Diosynth Biotechnologies (Fujifilm), a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and gene therapies, has announced the reduction of cell line development timelines with its Apollo X™ Advanced Mammalian Expression System....

Original Article: Fujifilm Announces The Introduction of a 10 week Cell Line Development Timeline with Its Apollo™ X Advanced Mammalian Expression System

NEXT ARTICLE

More From BioPortfolio on "Fujifilm Announces The Introduction of a 10 week Cell Line Development Timeline with Its Apollo™ X Advanced Mammalian Expression System"

Quick Search

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...